This week’s roundup is chock-full of updates and insights in two areas: EU regulations and US Medicare policy. There have been some important policy advancements in both spheres over the past week, but also continuing controversies.
With about five months to the MDR and 18 months to the IVDR, pressure is building in the EU. There were some points of progress for implementation of these new regulations in the past week, but also signs of potential setbacks. Those developments lead this week’s Pathways’ Picks, followed by US CMS updates and more on medtech policy from around the globe